We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
David Seiffge, MD
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Reinforcement of Principles, Overcoming Treatment Barriers, and Improving Time to Treatment for ICH
Audience Q&A
Improved Strategies for Treating Alcohol Use Disorder (AUD)
Edwin A. Salsitz, MD, DFASAM
Ethan A. Cowan, MD
Annie Levesque, MD, MSc
Epidemiology of AUD and Patient Stratification
Standardized Screening Tools for AUD
How, When, and Why to Conduct Brief AUD Interventions
Assessing a Patient’s Willingness to Accept Treatment for AUD
Strategies for Referral to AUD Treatment
Selecting an AUD Treatment: Naltrexone
Selecting an AUD Treatment: Acamprosate
Selecting an AUD Treatment: Disulfiram
Selecting an AUD Treatment: Off-Label Agents
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education